Innate Pharma
Price & Volume
Stats
See moreOpen | $1.49 |
Previous Close | $1.51 |
Day Range | $1.49-$1.49 |
52W Range | $1.17-$2.71 |
Market Cap | $160.8M |
Shares Short | 126,864 |
Financials
See moreRevenue (12 Mos) | $9.8M |
Revenue Growth (YoY) | 16.5% |
Gross Profit (12 Mos) | -$30.1M |
Diluted EPS | -$0.59 |
News
See moreYahoo Finance • 6 days ago
Innate Pharma Reports Third Quarter 2026 Business and Financial Update
Yahoo Finance • 15 days ago
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Yahoo Finance • 2 months ago
Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know
Yahoo Finance • 2 months ago
Innate Pharma Q2 Earnings Call Highlights
About
CEO | Mr. Jonathan E. Dickinson B.Sc., M.B.A. |
CFO | Mr. Frederic Lombard M.B.A. |
Address | 117, Avenue de Luminy, Marseille, France, 13009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 120 |